Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ELIZABETH A RAMIREZ DE ARELLANO

Allopathic & Osteopathic Physicians Radiology Diagnostic Radiology

NPI
1235155904
CMS profile
1081536
Location
MIDDLETOWN, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$91,855.00

123 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $91,855.00 123

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $91,605.00 122
PFIZER INC. $250.00 1

Page 2 of 3; records 51–100 of 123 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ELIZABETH A RAMIREZ DE ARELLANO

NPI 1235155904 · CMS profile ID 1081536

Allopathic & Osteopathic Physicians / Radiology / Diagnostic Radiology

MIDDLETOWN, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 123 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1235155904?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ELIZABETH A RAMIREZ DE ARELLANO, NPI 1235155904, CMS profile ID 1081536. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 123 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1235155904?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). ELIZABETH A RAMIREZ DE ARELLANO, NPI 1235155904, CMS profile ID 1081536. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 123 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1235155904?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
ELIZABETH A RAMIREZ DE ARELLANO, NPI 1235155904, CMS profile ID 1081536, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 123 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1235155904?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

123 matching records · $91,855.00 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 123 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 123.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme LLC $90.0008/02/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848437921 CMS
Merck Sharp & Dohme Corporation $840.0007/06/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848437765 CMS
Merck Sharp & Dohme Corporation $90.0007/06/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848437767 CMS
Merck Sharp & Dohme Corporation $60.0007/06/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848437925 CMS
Merck Sharp & Dohme Corporation $60.0007/06/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848437927 CMS
Merck Sharp & Dohme Corporation $180.0007/06/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848468313 CMS
Merck Sharp & Dohme Corporation $360.0007/06/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848545375 CMS
Merck Sharp & Dohme Corporation $300.0007/06/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848574943 CMS
Merck Sharp & Dohme Corporation $1,680.0007/06/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848677125 CMS
Merck Sharp & Dohme Corporation $3,340.0007/06/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848695061 CMS
Merck Sharp & Dohme Corporation $60.0007/06/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848734611 CMS
Merck Sharp & Dohme LLC $90.0007/06/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848468315 CMS
Merck Sharp & Dohme Corporation $480.0006/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848438181 CMS
Merck Sharp & Dohme Corporation $900.0006/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848438189 CMS
Merck Sharp & Dohme Corporation $120.0006/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848438973 CMS
Merck Sharp & Dohme Corporation $1,420.0006/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848438977 CMS
Merck Sharp & Dohme Corporation $60.0006/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848439227 CMS
Merck Sharp & Dohme Corporation $1,095.0006/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848527833 CMS
Merck Sharp & Dohme Corporation $450.0006/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848569141 CMS
Merck Sharp & Dohme Corporation $300.0006/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848615963 CMS
Merck Sharp & Dohme Corporation $270.0006/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848638723 CMS
Merck Sharp & Dohme Corporation $900.0006/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848734557 CMS
Merck Sharp & Dohme LLC $90.0006/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848569143 CMS
Merck Sharp & Dohme Corporation $240.0005/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848438171 CMS
Merck Sharp & Dohme Corporation $270.0005/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848438173 CMS
Merck Sharp & Dohme Corporation $60.0005/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848438183 CMS
Merck Sharp & Dohme Corporation $780.0005/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848438315 CMS
Merck Sharp & Dohme Corporation $1,080.0005/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848438971 CMS
Merck Sharp & Dohme Corporation $1,980.0005/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848438979 CMS
Merck Sharp & Dohme Corporation $660.0005/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848527505 CMS
Merck Sharp & Dohme Corporation $3,220.0005/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848586537 CMS
Merck Sharp & Dohme Corporation $420.0005/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848596779 CMS
Merck Sharp & Dohme Corporation $255.0005/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848638721 CMS
Merck Sharp & Dohme Corporation $270.0005/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848638809 CMS
Merck Sharp & Dohme LLC $360.0005/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848545283 CMS
Merck Sharp & Dohme Corporation $345.0004/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848438175 CMS
Merck Sharp & Dohme Corporation $1,900.0004/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848439223 CMS
Merck Sharp & Dohme Corporation $840.0004/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848468151 CMS
Merck Sharp & Dohme Corporation $75.0004/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848468317 CMS
Merck Sharp & Dohme Corporation $540.0004/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848487075 CMS
Merck Sharp & Dohme Corporation $400.0004/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848527731 CMS
Merck Sharp & Dohme Corporation $1,800.0004/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848531891 CMS
Merck Sharp & Dohme Corporation $75.0004/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848574825 CMS
Merck Sharp & Dohme Corporation $2,160.0004/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848638719 CMS
Merck Sharp & Dohme Corporation $420.0004/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848676939 CMS
Merck Sharp & Dohme Corporation $120.0004/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848734673 CMS
Merck Sharp & Dohme LLC $75.0004/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848487333 CMS
Merck Sharp & Dohme Corporation $360.0003/10/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848438177 CMS
Merck Sharp & Dohme Corporation $420.0003/10/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848438179 CMS
Merck Sharp & Dohme Corporation $600.0003/10/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848438185 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $80,325.00 68
PY2020 $124,540.00 122
PY2021 $91,855.00 123

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021
Generated from
OP_DTL_GNRL_PGYR2021_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $30,975.00 5
PY2024 Recipient $20,730.00 4
PY2023 Recipient $114,720.00 6
PY2022 Recipient $23,490.00 6
PY2021 Recipient $26,325.00 6
PY2020 Recipient $23,850.00 5
PY2019 Recipient $52,560.00 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

5 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient E.R. Squibb & Sons, L.L.C. $1,140.00 04/03/2025 Covered Recipient Physician A Phase 3, Open-label, Randomized Study of Nivolumab Combined with Ipilimumab, or with Standard of Care Chemotherapy, versus Standard of Care Chemotherapy in Participants with Previously Untreated Unresectable or Metastatic Urothelial Cancer No dispute reported 06/30/2026 1236002037
Recipient E.R. Squibb & Sons, L.L.C. $3,960.00 04/03/2025 Covered Recipient Physician A Phase 3, Randomized, Double-blind Study of Adjuvant Nivolumab versus Placebo for Participants with Hepatocellular Carcinoma after Curative Hepatic Resection or Ablation No dispute reported 06/30/2026 1236002041
Recipient E.R. Squibb & Sons, L.L.C. $22,575.00 01/03/2025 Covered Recipient Physician A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS 986205 in Participants with Muscle-Invasive Bladder Cancer No dispute reported 06/30/2026 1236002035
Recipient E.R. Squibb & Sons, L.L.C. $2,520.00 01/03/2025 Covered Recipient Physician A Phase 2 Clinical Trial of Nivolumab, or Nivolumab Combinations in Recurrent and Metastatic Microsatellite Instability High (MSI-H) and Non-MSI-H Colon Cancer No dispute reported 06/30/2026 1236002039
Recipient Eli Lilly and Company $780.00 01/03/2025 Covered Recipient Physician A STUDY OF SELPERCATINIB (LY3527723) IN PARTICIPANTS WITH ADVANCED OR METASTATIC RET FUSION-POSITIVE NON-SMALL CELL LUNG CANCER (LIBRETTO-431) No dispute reported 06/30/2026 1187870973